PROAIR

Drug Teva Pharmaceuticals USA, Inc.
Total Payments
$295,512
Transactions
7,729
Doctors
3,399
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $13,268 1 0
2021 $16.54 1 1
2020 $1,926 127 93
2019 $23,695 208 108
2018 $9,572 300 117
2017 $247,034 7,092 3,206

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $130,197 506 44.1%
Food and Beverage $116,227 7,211 39.3%
Consulting Fee $31,390 7 10.6%
Unspecified $13,268 1 4.5%
Honoraria $4,400 1 1.5%
Education $28.91 3 0.0%

Payments by Type

General
$282,243
7,728 transactions
Research
$13,268
1 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Albuterol Integrated Adherence Monitoring in Children with Asthma Teva Pharmaceuticals USA, Inc. $13,268 0

Top Doctors Receiving Payments for PROAIR — Page 134

Doctor Specialty Location Total Records
, DO Allergy & Immunology Springfield, MA $8.25 3
, M.D Family Medicine Madison, MS $8.09 1
Suresh Anand Tempe, AZ $8.00 1
, MD Allergy & Immunology Baltimore, MD $7.87 1
, M.D Allergy & Immunology Little Rock, AR $7.87 1
, M.D Allergy & Immunology Owensboro, KY $7.72 1
, M.D Allergy & Immunology Lutherville, MD $7.72 1
, MD Critical Care Medicine Cincinnati, OH $7.70 2
, M.D Internal Medicine Annandale, VA $7.35 2
, DO Pulmonary Disease Coatesville, PA $7.22 1
, M.D Critical Care Medicine Woodbury, NJ $7.14 1
, D.O Allergy & Immunology Opelika, AL $7.04 1
, M.D Internal Medicine Greensboro, NC $7.04 2
, MD Allergy & Immunology Washington, DC $6.93 2
, M.D Pulmonary Disease Los Angeles, CA $6.77 1
Anthony Demeo Walnut Creek, CA $6.69 1
, MD Pulmonary Disease Bethlehem, PA $6.61 1
, D.O Allergy & Immunology Olympia, WA $6.56 1
, M.D Pulmonary Disease Shelbyville, IN $6.49 1
, MD Internal Medicine Edison, NJ $6.46 2
, MD Allergy & Immunology Charlotte, NC $6.40 1
, M.D Allergy & Immunology Saint Louis, MO $6.37 3
, MD Allergy Lexington, KY $5.64 2
, M.D Allergy Bandera, TX $5.39 1
, MD Pulmonary Disease Toms River, NJ $5.31 1

About PROAIR

PROAIR is a drug associated with $295,512 in payments to 3,399 healthcare providers, recorded across 7,729 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..

Payment data is available from 2017 to 2024. In 2024, $13,268 was paid across 1 transactions to 0 doctors.

The most common payment nature for PROAIR is "Travel and Lodging" ($130,197, 44.1% of total).

PROAIR is associated with 1 research study, including "Albuterol Integrated Adherence Monitoring in Children with Asthma" ($13,268).